NV
Novo Integrated Sciences, Inc.
NVOS · OTC
$0.00 +0.00% (+$0.00)
1M +550.00%
Market Cap $76.9K
P/E Ratio -
Div. Yield -
ROE 91.57%
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/B 0.01x
P/S 0.01x
EV/FFO N/A
Growth
61 /100
Stable Book val. growth 30.24%
Rev. growth 12.63%
FCF growth N/A
Profitability
17 /100
Weak Op. margin 62.54%
Gross margin 43.20%
FCF margin 38.17%
Quality
5 /100
Poor ROA 50.30%
ROIC 40.13%
Asset turnover 0.41x
Debt
46 /100
Moderate Int. coverage -1.23x
Debt/Equity 0.32x
Current ratio 0.37x
Stability
26 /100
Unstable EPS volatility 339.72%
Beta 5.83x
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre NVOS
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Robert Mattacchione
Employees
115
Headquarters
Bellevue